News Releases

Marla Keller, M.D., Named Director of the Block Institute for Translational and Clinical Research at Einstein and Montefiore
Lauren Hackett, M.P.A., to Lead Operations at NCI-Designated Albert Einstein Cancer Center
Promising Therapy for a Lethal Tick-Borne Viral Infection

Facts & Stats

Published Papers
NIH Research Funding
Students
Full-time Faculty
Global Initiatives
Clinical and Research Centers
Alumni

Expert List for Media

Joel Zonszein

Joel Zonszein, M.D.

Area(s) of expertise: Diabetes (clinical)Type 1 diabetesType 2 diabetes

Dr. Zonszein is an experienced clinician and researcher who focuses on preventing and treating types 1 and 2 diabetes. He has participated in landmark NIH studies, including the Diabetes Control and Complications Trial… Learn more

Einstein in the News


ABC News
Doctors Treating Depression See Promise in Ketamine, a Cheap Drug Already Approved for Anesthesia

Panagiota Korenis, M.D., discusses both problems and potential benefits of using ketamine for treating people with depression. Dr. Korenis is associate professor of psychiatry and behavioral sciences at Einstein.

New York Post
Inside the Billionaire-Funded Fight to Conquer Aging—and Cheat Death

Nir Barzilai, M.D., talks about his plans for a clinical trial to study metformin, a diabetes drug, to target age-related diseases. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.

More coverage on Dr. Barzilai

Medscape
Matthew Akiyama, MD, Receives Avenir Grant for Efforts to Hinder HIV/HCV Transmission in Kenya

Matthew Akiyama, M.D., describes his National Institutes of Health award to use new sequencing technology to understand HIV and hepatitis C transmission, which may lead to new prevention and treatment strategies for the diseases. Dr. Akiyama is associate professor of medicine at Einstein and an internist at Montefiore.

More coverage on Dr. Akiyama

Multimedia

When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog